• Tekedia Capital invested in Exonic, an unsupervised biological AI company building biological foundation models for heterogeneous, noisy datasets.
• The transaction was described as an equity investment; financial terms were not disclosed.
• The investment thesis centers on scaling biological AI by learning across broad, unstructured data sources rather than narrowly curated datasets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tekedia Capital LLC published the original content used to generate this news brief on May 30, 2026, and is solely responsible for the information contained therein.